Advertisement

Topics

Companies Related to "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" [Most Relevant Company Matches] - Page: 5 RSS

19:48 EDT 19th March 2019 | BioPortfolio

Here are the most relevant search results for "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" found in our extensive corporate database of over 50,000 company records.

Showing "Study Assess Safety Dose Conversion Dose Individualization Duragesic" Companies 101–125 of 2,200+

Relevant

SightLine Health

SightLine Health, headquartered in Houston, Texas, specializes in groundbreaking cancer treatments such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), high-dose-rate (HDR) brachytherapy, and electron-beam radiation therapy. The company opened its first facility, near the renowned Texas Medical Center, in 2005. Today...


ScandiDos

ScandiDos is the innovative company that introduced the new QA standard in advanced radiotherapy by moving into the era of 3D and 4D volumetric dosimetry. Founded in 2002 by a group of highly experienced physicists and engineers, ScandiDos grew out of a recognized need for practical clinical solutions for new advanced radiation therapy technologies. ScandiDos mission is to provide complete dosimet...

AAIPharma Services, Corp.

AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. have joined to form a world-class supplier of comprehensive pharmaceutical development and manufacturing services. With nearly 800 employees operating out of seven sites in the US and Europe, combined capabilities include API development and manufacturing, solid state chemistry, formulation de...


Zoloft

Zoloft is well tolerated and effective for the treatment of depression and certain types of anxiety disorders. Zoloft is FDA approved to treat depression, social anxiety disorder, posttraumatic stress disorder (PTSD), panic disorder, obsessive-compulsive disorder (OCD), and premenstrual dysphoric disorder (PMDD) in adults over age 18. It is also approved for OCD in children and adolescents age 6-1...

Saladax Biomedical Inc.

Founded in 2004, Saladax Biomedical, Inc. is a privately held company headquartered as an anchor tenant with Ben Franklin TechVentures® located in Bethlehem, PA. Saladax develops rapid blood tests to increase the impact of personalized medicine by bringing adherence testing to psychiatrists and chemotherapeutic drug monitoring to oncologists. The compan...

ViewRay Incorporated

ViewRay Incorporated is developing an advanced system to treat cancer patients: the world's first real-time MRI guided radiation therapy device. The Renaissance(TM) System technology will continuously image the patient in three dimensions during radiation therapy delivery. This real time imaging will control the delivery of the radiation therapy and record the dose delivered to the patient, allowi...

Radius

RAD1901 is a potential first-in-class novel selective estrogen receptor modulator (SERM) under development at Radius for menopausal hot flashes. SERMs are small molecules that bind to and selectively modulate estrogen receptors. These molecules have the ability to stimulate or block estrogen's activity in different types of tissue, functioning as estrogen receptor agonists in some tissues and as e...

Cianna Medical, Inc.

Cianna Medical, Inc. is a medical device company focused on women's health and dedicated to the innovative treatment of early-stage breast cancer. The company manufactures and markets the SAVI breast brachytherapy applicator, for the delivery of radiation after lumpectomy surgery. The SAVI applicator allows precise sculpting of the radiation dose, and is d...

LifeSavers, Inc.

LifeSavers, Inc., provides emergency medical response products and training to businesses, the public sector, and other organizations nationwide. LifeSavers works closely with its customers to design, implement and continually assess safety and emergency response programs. The company is an authorized distributor for the Defibtech Lifeline AED® (automat...

Pharma Tech Industries

Pharma Tech Industries (PTI) has been serving the supply chain needs of leading global pharmaceutical and personal care companies with manufacturing, packaging, and molding services for over 35 years. Today PTI is the largest pharmaceutical contract manufacturer of powder-based products in the world, with extensive background in technology transfers. PTI c...

PMC BioTec

PMC BioTec is a global leader in disruptive microbial and anaerobic process technology which facilitates breakthrough bio-refinery economics, profitable algae-based carbon sequestration, and economic onsite sludge conversion to energy and clean water. AFC(TM) technology is an industry standard for 100% onsite elimination of sludge with recent advances in molecular manipulation and microbe developm...

Accu-Break Pharmaceuticals, Inc.

Accu-Break Pharmaceuticals, Inc. (ABP) is a technology licensing and product development company. ABP has invented, developed and patented a suite of novel Accu-Break™ technologies that enable pharmaceutical tablets to be made that can be subdivided by hand into accurate partial doses with the intent of making it easier and safer for patients to adjus...

Midway Pharmaceuticals

Midway Pharmaceuticals is an emerging pharmaceutical company focused on developing proprietary drugs for the treatment of gastrointestinal diseases. The company’s platform technology capitalizes on the finding that certain high molecular weight polymers, taken orally but not systemically absorbed, can inhibit the pathogenic behavior of bacteria in the...

Advanced Biomedical Research, Inc

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in the heart of New Jersey's pharmaceutical R&D corridor in Princeton, NJ. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and clinical data ...

Efficient Power Conversion

Elevation Pharmaceuticals, Inc.

Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease. The Company was founded in 2008 by Cam Garner, formerly Chairman and CEO of Dura Pharmaceuticals, Bill Gerhart, formerly President and CEO of Mpex Pharmaceuticals, and Ahmet Tutuncu, formerly VP of Medical Affairs at Verus Pharmaceuticals. The Company's init...

GlycoGenesys, Inc.

GlycoGenesys, Inc. is a biotechnology company that develops and licenses products based on glycobiology. The Company's human therapeutic product, GCS-100, a unique compound to treat cancer has been evaluated in Phase II(a) human clinical trials for both colorectal and pancreatic cancers. In February 2002, the Company initiated a Phase I dose escalation trial of GCS-100 up to 80 mg/m2 at Sharp Clin...

AVROBIO, Inc.

AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical-stage company developing disruptive therapies that have the potential to transform patients’ lives with a single dose. The Company is focused on the development of its Phase 1 program in Fabry disease and pre-Phase 1/2 program in Gaucher disease, while actively building a pipeli...

Neurodyn Cognition Inc.

NCI is a private Canadian biotech company developing Memogain, a patented prodrug of an approved treatment for Alzheimer’s disease, galantamine (Reminyl®). Memogain’s intranasal administration achieves higher dose levels, with significantly greater brain bioavailability, while avoiding the compliance impairing gastro-intestinal adverse effects...

DSM Pharmaceutical Products

DSM Pharmaceutical Products is a global provider of high quality custom contract manufacturing and development services to the pharmaceutical and biopharmaceutical industries. DSM contract manufacturing services include: chemical development, registered intermediates, registered starting materials, active pharmaceutical ingredients (API's), mammalian cell production of monoclonal antibodies and pr...

InfuSystem Holdings, Inc.

InfuSystem is the leading provider of ambulatory infusion pumps and associated clinical services for oncology practices and their patients in the U.S. These pumps allow for the gradual delivery of a drug over a period of days in the privacy of one's home, compared to bolus infusion chemotherapy treatments that are given in a single high dose over a short period of time. Improved efficacy of the dr...

Patton Medical Devices

Headquartered in Austin, Texas, Patton Medical Devices is the manufacturer of the i-port(R) Injection Port. For people taking injections who want to minimize the intrusion of injections on daily life, the i-port(R) is the only product of its kind conceived by a person with diabetes that offers a simple, convenient way to eliminate the need to puncture the skin with each dose of medication. The i-p...

Coromega

Originally formulated by a Norwegian scientist searching for a way to encourage his granddaughter to take her daily dose of fish oil, Coromega was developed after more than 10 years of experimenting and trial and error. The delicious and innovative emulsion technology gained a United States patent in the early 1990s, and in 1999 Coromega was launched. Toda...

Hollis-Eden Pharmaceuticals, Inc.

Hollis-Eden Pharmaceuticals is a development-stage company with two product candidates in clinical trials: Apoptone® (HE3235), in the dose-escalation portion of a Phase I/II trial of patients with late-stage prostate cancer, and Triolex®, in a Phase IIa trial in obese type 2 diabetes mellitus patients. Apoptone® and Triolex® represent the lead candidates from Hollis-Eden's small molecule pla...

Inotek Pharmaceuticals Corp.

Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other eye diseases. The Company’s lead product candidate, trabodenoson, is a first-in-class selective adenosine mimetic developed in Inotek’s laboratories designed to restore the eye’s ...


More From BioPortfolio on "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks